Company Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.
The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 1,057 |
| CEO | Thomas Frinzi |
Contact Details
Address: 25651 Atlantic Ocean Drive Lake Forest, California 92630 United States | |
| Phone | 626 303 7902 |
| Website | staar.com |
Stock Details
| Ticker Symbol | STAA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000718937 |
| CUSIP Number | 852312305 |
| ISIN Number | US8523123052 |
| Employer ID | 95-3797439 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Thomas G. Frinzi | President, Chief Executive Officer and Chairman |
| Patrick F. Williams | Chief Financial Officer |
| Warren Foust | Chief Operating Officer |
| Dr. Keith Holliday Ph.D. | Chief Technology Officer |
| Dr. Scott D. Barnes M.D. | Chief Medical Officer |
| Brian Moore | Vice President of Investor Relations and Corporate Development |
| Nathaniel B. Sisitsky Esq. | General Counsel and Corporate Secretary |
| Nancy Sabin | Chief Marketing Officer |
| James Francese | Senior Vice President of Commercial Operations - North America and APAC |
| Dr. Magda Michna Ph.D. | Chief Clinical, Regulatory and Medical Affairs Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 31, 2024 | 8-K/A | [Amend] Current report |
| Oct 30, 2024 | 10-Q | Quarterly Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Aug 7, 2024 | 8-K | Current Report |
| Jun 21, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 21, 2024 | 8-K | Current Report |